TFA Therapeutics annual ebitda margin
2021
2022
2023
2024
2025
TFA Therapeutics EBITDA Margin Growth & History (RAJAF)
TFA Therapeutics's ebitda margin was −0.47% for fiscal 2025.
View full TFA Therapeutics company overviewTFA Therapeutics annual ebitda margin history
| Fiscal year | Period ended | EBITDA margin | Change (percentage points) |
|---|---|---|---|
| 2025 | 2025-12-31 | −0.47% | −18.29 pp |
| 2024 | 2024-12-31 | 17.82% | −14.43 pp |
| 2023 | 2023-12-31 | 32.25% | +765.08 pp |
| 2022 | 2022-12-31 | −732.84% | −736.23 pp |
| 2021 | 2021-12-31 | 3.39% | — |
TFA Therapeutics ebitda margin trends
Between the periods ended 2021-12-31 and 2025-12-31, TFA Therapeutics's ebitda margin decreased from 3.39% to −0.47%, a change of −3.87 percentage points.
About the metric
What EBITDA margin means
EBITDA margin measures EBITDA as a percentage of revenue. It can help compare operating profitability over time, but it excludes capital intensity, financing costs, taxes, and other items and is generally unsuitable for financial companies.
Calculation and source
How EBITDA margin is calculated
TickerStat calculates EBITDA margin as EBITDA divided by positive reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review TFA Therapeutics source filings ↗